ATAGI update following weekly COVID-19 meeting – 16 March 2022

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 16 March 2022.

Date published:
General public

Latest recommendation updates

ATAGI have not made any new updates since 9 March 2022.

Recent ATAGI considerations

On Wednesday 16 March 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation.  As of 14 March 2022, over 55 million doses of COVID-19 vaccines have been administered in Australia.

ATAGI encourages parents of children aged 5-11 to make an appointment for the second dose of COVID-19 vaccine. ATAGI also encourages anyone aged 16 years and over to receive a booster dose as soon as they are eligible.

Upcoming ATAGI considerations

Evidence relating to second COVID-19 booster doses

ATAGI is currently finalising advice to the Minister for Health on the need for a winter dose of COVID-19 vaccine, particularly for older people, who are at a high risk of severe disease.

The development of this advice is based on a thorough review of all the current and emerging evidence on COVID-19 booster doses, including data on effectiveness, waning of immunity, international program settings, national vaccination coverage and operational flexibility where appropriate.

ATAGI will continue to regularly review the data on use of COVID-19 boosters and the epidemiology in Australia during autumn and winter, updating advice to the Government as required.

COVID-19 vaccine safety

The TGA Weekly Report provides a detailed breakdown of adverse events following immunisation.

Resources and recent statements

ATAGI recommends review of the following key resources:

More information can be found on the Department of Health website, with resources for both providers and patients.

Help us improve

If you would like a response please use the enquiries form instead.